The Execution Layer for Regulated Life Sciences.

▹ Orchestrate + Automate Processes. Unify Data. 

▹ Cut Lead Times. Reduce Operational Costs.

▹ Accelerate Science with AI-Actionable Data. 

FROST & SULLIVAN NAMES L7 GLOBAL LEADER IN INNOVATION

L7 achieves the highest innovation Score in 2025 Frost & Sullivan Frost Radar™ for Pharmaceutical and Biotech LIMS.

fragmented systems are blocking your AI ambitions

Drug development is getting harder and more expensive. On paper, AI offers a genuine path forward, but most organizations are facing the same obstacle: the operational foundation needed to deploy AI at scale simply is not there yet. Disconnected systems, fragmented workflows, and data that cannot be contextualized at the source slow work down, drive up costs, and leave AI initiatives stuck in pilot mode.

10 years 

According to McKinsey, that’s how long it takes, on average, to deliver new treatments, with inefficiencies dragging out every phase.

$2.67B

Deloitte states that the average cost to develop a drug continues to climb, reaching $2.67 billion in 2025, and putting strain on R&D and manufacturing.

95%

A 2025 McKinsey report indicates that 95% life sciences organizations have yet to realize AI as a competitive advantage.

L7|ESP®: the execution layer that makes AI actionable

AI is only as powerful as the data behind it. In life sciences, fragmented systems, inconsistent ontologies, and disconnected workflows create a gap between AI ambitions and AI outcomes. L7|ESP closes that gap. The platform contextualizes data at the source, orchestrates end-to-end processes across research, development, manufacturing, and quality, and provides the unified operational foundation organizations need to run AI at scale.

L7|ESP is the execution layer and the digital backbone of regulated science. With platform components including L7|SYNAPSE, L7|MASTER, L7|HUB, L7|INTELLIGENCE, and L7|EXCHANGE, it delivers AI-actionable data, seamless orchestration, and cross-functional operational continuity at every stage of the scientific lifecycle.

L7|ESP layers over existing systems. No rip-and-replace required.

context is not a feature: it’s the foundation

L7|ESP is built on an ontology-driven knowledge graph, designed into the platform from day one. Every experiment, process, sample, instrument, reagent, and outcome is stored with its relationships intact. Context is structural, not inferred.

This is what makes data AI-actionable at the point of generation rather than after rounds of cleanup, transformation, and tagging. It is also what allows L7|SYNAPSE to operate as a true agentic layer: agents working on data that already understands itself.

And L7 has been doing this since the beginning.

A visualization of the L7|ESP knowledge graph, showing interconnected blue and pink nodes linked by lines on a black background, representing complex relationships between data points across manufacturing processes in life sciences.

L7 IS A DELOITTE FAST 500 COMPANY

We’ve been listed in the Deloitte Fast 500 annual ranking of fastest-growing companies for the 4th consecutive year. What an honor!

what L7|ESP makes possible

Digital Unified Platform

L7|ESP connects and orchestrates lab and manufacturing workflows, contextualizing data at the source and making it AI-actionable across the scientific and operational continuum.

  • Seamless integration: Works with instruments, equipment, and legacy systems.
  • Data contextualization: Captures data at the point of generation, eliminating complex downstream transformations.
  • Reduced IT overhead: Minimizes manual intervention and simplifies data management.
  • Real-time insights: Transforms raw data into actionable intelligence without degradation over time.
  • Adaptable in any IT landscape: Supports both legacy-heavy (brownfield) and newly established (greenfield) environments.
  • More than a data lake: A fully digital unified platform with built-in LIMS, ELN, MES, Scheduling apps, and more.

Compliance + AI-Actionable by Design

L7|ESP is built for GxP-regulated environments, including GLP, GCP, and GMP, structuring data at the point of execution to ensure integrity, traceability, and AI actionability by design.

  • Complete audit trail: Captures instruments, reagents, media, and personnel for every experiment or process.
  • Automatic data contextualization: Eliminates the need for complex ETL pipelines and siloed storage.
  • AI-actionable foundation: Organizes data for seamless AI/ML training, including LLMs.
  • Enhanced regulatory compliance: Simplifies audits, submissions, and root cause analysis.
  • Single source of truth: Ensures structured, intact, and contextualized data for improved decision-making.

Rapid Tech Transfers

L7|ESP streamlines internal and external tech transfers, accelerating time-to-market for drug products, biologics, and diagnostics.

  • Seamless digital transfers: Eliminates process variations and the need to revert to paper.
  • Unified data + processes: Ensures consistency across research, development, clinical trials, and commercialization.
  • GxP-compliant: Maintains data integrity and harmonization throughout the product lifecycle.
  • CRO/CDMO-ready: Enables smooth collaboration with external partners.
  • Faster scale-up + commercialization: Reduces delays and inefficiencies in tech transfer.

Portfolio Optimization

L7|ESP simplifies IT ecosystems, reducing costs and freeing resources for innovation.

  • Eliminates redundancies: Orchestrates interactions across legacy systems, instruments, and equipment.
  • Reduces IT complexity: Streamlines architecture to optimize resource allocation.
  • Future-proof framework: Supports both monolithic and next-gen solutions.
  • Phased system transitions: Enables seamless onboarding and retirement of technologies.
  • Unlocks AI + ML potential: Frees budgets for transformative technologies like Gen AI, machine learning, and Agentic AI.

Operational Excellence

L7|ESP unifies research, lab, and manufacturing operations, eliminating inefficiencies and enhancing visibility by answering questions such as ‘What is the utilization of my lab resources?”, “When will my test be completed?”, or “What is delaying my batch release?

  • End-to-end integration: Connects ELN, LIMS, MES, and Scheduling in a single platform.
  • Optimized workflows: Replaces paper-based processes to improve efficiency.
  • Material + capacity management: Ensures better resource utilization.
  • Real-time operational insights: Provides answers to critical questions on test timelines, batch delays, and resource allocation.
  • Smarter decision-making: Enhances visibility across Research, Development, and Manufacturing.

blog posts

Why Life Sciences Manufacturing AI Keeps Failing at the Finish...

Between 70% and 90% of AI initiatives in manufacturing never reach production. The reasons are rarely about the AI itself.
document
Blog

Agentic AI in Life Sciences: What’s Real, What’s Hype, and...

Agentic AI is maturing fast, but the honest picture is earlier than most vendors admit. L7 Informatics experts James Ryan,
document
Blog

Cell Therapy Cannot Scale Without Digital Continuity Across R&D, CMC,...

Cell therapy programs don't fail because of bad science; they fail because context doesn't travel. This article explores how ontologies,
document
Blog

Modernization was the First Chapter, Digital Differentiation is the Next...

Life sciences organizations have invested heavily in digital transformation, but modernization alone does not create a competitive advantage. Vasu Rangadass,
document
Blog

meet us at

Future Labs Live USA 2026

10/28/26 - 10/29/26
Philadephia, PA
BOOK A MEETING

latest news

Vasu Rangadass on Integrated Platforms for Regulated Industries

The Silicon Review features L7 Informatics and Vasu Rangadass, Ph.D., highlighting how L7|ESP helps regulated scientific organizations move beyond fragmented
webpage

Eliminating Data Silos in High-Stakes CGT Manufacturing

In this Life Sciences Review article, Marcia Blackmoore discusses how L7|ESP eliminates data silos in cell and gene therapy manufacturing.
webpage

L7 Informatics Announces L7|SYNAPSE, Advancing Context-Aware AI for Regulated Scientific...

L7 Informatics announced the launch of L7|SYNAPSE™, an agentic AI layer built on the L7|ESP platform, designed to make artificial
webpage

L7 Informatics Announces L7|SYNAPSE, Advancing Context-Aware AI for Regulated Scientific...

L7 Informatics announced the launch of L7|SYNAPSE™, an agentic AI layer built on the L7|ESP platform, designed to make artificial
webpage

recent case studies

Case Study: Building a Digital Foundation for Scientific Innovation with...

A global leader in biological reference materials partnered with L7 to replace paper-based workflows with a unified digital platform. By
document
Case Study

Case Study: Advancing DNA Sequencing Services in a Public Sector...

A national agri-food research organization replaced its outdated system with L7|ESP® to streamline DNA sequencing workflows, improve traceability, and automate
document
Case Study

Case Study: Modernizing Agricultural Trait Development with a Configurable Digital...

A leading Ag-Bio company replaced its legacy LIMS with L7|ESP® to streamline trait development workflows, empower internal teams, and prepare
document
Case Study

Case Study: Supporting Cellipont Bioservices in Their Mission to Advance...

L7|ESP, with L7 MES, brings organizational excellence and efficiency to Cellipont’s cell and gene therapy processes by digitalizing and centralizing
document
Case Study

FAQ: L7 in 7 questions

What does L7 Informatics do?

L7 Informatics builds the execution layer for regulated science. Its flagship platform, L7|ESP®, is a digital unified platform that contextualizes data at the point of generation, orchestrates workflows across research, development, manufacturing, and quality, and provides the operational foundation life sciences organizations need to make AI actionable at scale.
L7|ESP brings scientific and operational data, workflows, applications, instruments, and enterprise systems into a single digital environment. L7 serves pharmaceutical companies, biotechs, CDMOs, diagnostics organizations, cancer centers, CROs, and research institutions at every stage of growth.

What problem does L7|ESP solve for life sciences organizations?

L7|ESP solves the data fragmentation problem that blocks operational efficiency and AI expansion in life sciences. Most organizations run on disconnected systems, each with its own language, logic, and limits. The result is redundant processes, inaccessible data, and AI ambitions that outpace the infrastructure needed to support them.
Drug development slows, costs rise, and teams spend more time moving data than acting on it. L7|ESP closes that gap by unifying data and orchestrating workflows across research, development, manufacturing, and quality, giving organizations the shared operational context they need to operate as one connected enterprise.

How is L7|ESP different from traditional LIMS, ELN, MES, or point solutions?

L7|ESP is different in kind, not just in scale, from traditional LIMS, ELN, MES, and other point solutions. Point solutions are typically built to solve one problem in isolation. They may capture data, but they often leave organizations relying on custom integrations, manual handoffs, and workflow boundaries that become operational failure points.

L7|ESP contextualizes data at the source using ontology-driven knowledge graphs, orchestrates processes end-to-end, and delivers built-in LIMS, ELN, MES, and scheduling capabilities within a single unified platform. It can also layer over existing infrastructure without requiring rip-and-replace, enabling organizations to unify operations without starting over.

How does L7|ESP make AI actionable across scientific and operational workflows?

L7|ESP makes AI actionable by structuring data at the point of execution, before it becomes siloed, degraded, or disconnected. Using ontology-driven knowledge graphs, the platform captures context alongside raw data, linking instruments, reagents, personnel, process parameters, experimental conditions, and outcomes at the moment of generation.
This gives AI, machine learning, analytics, and automation workflows access to data that is structured, traceable, and grounded in scientific and operational context. Instead of depending on downstream data cleanup and transformation, L7|ESP gives organizations the execution foundation needed to scale AI across regulated life sciences operations.

What role does L7 play in agentic AI for life sciences?

L7 provides the operational foundation that makes agentic AI viable in regulated scientific environments. Agentic AI systems, including autonomous agents that plan, reason, and act across multi-step workflows, require structured, contextual, and trustworthy data to function reliably. Without an execution layer that ensures data integrity and context at the source, agents operate on incomplete or inconsistent information and are difficult to deploy safely in regulated settings.

L7|SYNAPSE™, L7|ESP’s agentic AI layer, enables context-aware AI that works directly within scientific and manufacturing workflows. It gives agents access to governed, structured data and the operational harness needed to support action with traceability, control, and compliance.

Can L7|ESP work with existing systems and legacy infrastructure?

Yes. L7|ESP is designed to layer over existing IT infrastructure rather than replace it. The platform integrates with instruments, equipment, legacy systems, and enterprise applications, allowing organizations to adopt L7|ESP incrementally and expand capability over time as their digital maturity grows.

This applies equally to brownfield environments with decades of legacy investment and greenfield organizations building from scratch. Organizations do not need to choose between modernizing and protecting prior investments. L7|ESP connects what already exists, fills the gaps between point solutions, and creates a unified operational layer across the technology landscape.

Is L7|ESP designed for regulated life sciences environments?

Yes. L7|ESP is built for GxP-regulated life sciences environments, including GLP, GCP, and GMP operations. The platform supports audit trails, electronic records and signatures, chain of custody, workflow control, and data integrity requirements across complex scientific and operational processes.
Because data is contextualized at the point of execution, traceability is structural rather than retrofitted. This enables teams to support regulatory submissions, audits, investigations, and root cause analysis with connected data and process context. L7|ESP also supports tech transfer between internal teams and external CRO and CDMO partners while maintaining the data integrity, harmonization, and operational continuity required in regulated environments.